iMDx posts Q2 loss as FDA review of GraftAssureDx continues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| BIO-RAD LABORATORIES (NYSE: BIO) | Delayed: 377.53 +5.10 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $372.43 | 52 Week High | $174.02 | |||
| Open | $376.25 | 52 Week Low | $122.03 | |||
| Day High | $377.67 | P/E | 122.18 | |||
| Day Low | $369.33 | EPS | $3.09 | |||
| Volume | 14,672 | |||||
| (NASDAQ: IMDX) | Delayed: 3.03 +0.03 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.00 | 52 Week High | $ | |||
| Open | $3.06 | 52 Week Low | $ | |||
| Day High | $3.07 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $ | |||
| Volume | 22,418 | |||||
